Rough Road Ahead, but U.S. Personal Care Sales March Onwards
The cosmetics and toiletries market continues to move upward, but is still influenced by societal and economic trends. Despite the recent struggles, total U.S. sales exceeded $41 billion at the manufacturers’ level in 2013 and are up 2.4% from 2012 levels. Backed by the strong performance of the makeup and skin care product classes, the market has seen revenue growth for the fourth consecutive year. Furthermore, a few mature product classes, such as hair care and oral care, contribute to the market’s overall growth, signaling that companies are making inroads leveraging innovation and new products to keep their revenue streams buoyant.Continue reading
Sales Resurgence of U.S. OTCs in 2013 Helps the Market Overcome Flat Sales Performance of the Past
According to Kline’s Nonprescription Drugs USA study, the U.S. OTC market grew over 3.0% during 2013 to reach $23.5 billion at the manufacturers’ level. Driven by strong sales gains in analgesics, upper respiratory, nutritional, and topical products, the market appears to be showing signs of recovery. This is partly due to the long-awaited rejuvenation of several brands that have posted steep declines in the recent past as a result of supply disruptions and recalls. Brands such as Novartis’ Excedrin and Johnson & Johnson’s Tylenol and Motrin IB have experienced strong gains in 2013 thereby helping the analgesics category to post very strong gains this past year while Pfizer’s Advil, Bayer’s Aleve, and private-label analgesics also posted gains in 2013. Continue reading
Kline’s March Index of Base Stock Production and Re-refining Cash Margins Shows Further Drop in Base Stock Profitability
Two months ago, Kline & Company introduced its monthly Base Stock Margin Index, a characterization of recent cash margin contributions in the U.S. base oil market over the past 24 months.
The Index estimates cash margin contributions associated with U.S. Group II base stock production. It simulates EBITDA before the deduction of corporate SG&A expenses for typical VGO-based virgin base stock plants and RFO-based re-refineries. A more detailed description of the Margin Index can be found in the January release.Continue reading
A Beautiful Partnership: Enchanted Life and Kline & Company
Purchase, Learn, and Share … A One-stop Site That Goes Beyond Beauty
What is beauty? It is very subjective and often its definition varies from country to country and culture to culture. In an exciting new partnership, Kline & Company and Enchanted Life, recognizing that the world of beauty isn’t just black and white, have partnered together to maximize customer satisfaction. Enchanted Life’s one-stop website for beauty and lifestyle needs targets multicultural demographic groups in the United States. By joining forces with Kline, it will be able to tap into Kline’s long-respected personal care market research portfolio. Embarking upon its first partnership with an e-commerce beauty site, Kline will benefit from valuable insights into this highly promising market.Continue reading
Kline Announces 8th Edition of its LubesNet Database
The global lubricants market is flat, up only 1% with an estimated 39.1 million tonnes in 2013 compared to 38.8 million tonnes in 2012. In terms of lubricants volume consumed, the United States continues to be the largest country market, although its total global volume has now dropped from 25% to below 22%. Interestingly, Russia has surpassed Japan and is now the fourth largest country market. Both North America and Western Europe continue to stagnate below pre-recession levels. Though Asia and other developing regions picked up in 2011, the market lost steam in 2012, most notably in China, down 1.1%.Continue reading
Rejuvenating Trends at the Professional Beauty 2014
For the last 25 years, the Professional Beauty Show in London has been serving as the beauty platform for industry professionals and clients to learn about new trends in skin care products and their most efficient application. This year, the show brought together more than 600 brands from every area of the industry including skin care, aromatherapy, spa, advanced treatments, nails, makeup, tanning, and equipment, increasing the presence of brands from overseas. Major brands chose Professional Beauty as the platform for their new launches; skin care brand Elemis showcased its first treatment machine Biotec, distributor Louella Belle introduced its latest addition IBX to the nail fanatics, and equipment brand 3D-Lipo showed off the much anticipated 3D-Lipolite system.Continue reading
Exchanging Ideas with the Legendary Dr. Robb: From Skin Care Concerns to New Technology
Which beauty segments are enjoying the fastest growth? What’s driving this growth? Questions like these were addressed recently by Kline’s very own Carrie Mellage, Vice President of Consumer Products. On February 18, 2014, Carrie had the privilege of participating in a panel discussion with Pam Busiek, President and CEO of Independent Cosmetics Manufacturers and Distributors (ICMAD), and the legendary Dr. Robb Akridge, founder of Clarisonic, at the 2014 Global Beauty & Wellness Exchange held at the Ritz-Carlton in Amelia Island, FL. Continue reading
The Beauty of Skin…Naturally: A Postcard from VIVANESS 2014
This year marks the 25th anniversary of the organic cosmetics industry trade show VIVANESS. Each year, the show’s host city Nuremberg welcomes natural beauty lovers, who can also satisfy their taste buds with the sampling of natural food novelties displayed at the sister show, BIOFACH.
The 2014 VIVANESS show surprised visitors with a myriad of novelties and trends, which are set to hit shelves this spring.Continue reading
U.S. Rx-to-OTC Switch Progression
Infographic representing the U.S. Rx-to-OTC Switch Progression. Download the file here or copy paste the link: https://bit.ly/1cQBmWw
Broader Opportunities in Rx-to-OTC Switch
There have been signs recently indicating that the environment is becoming ripe for more Rx-to-OTC switches. Since we last reported on this topic in August 2013, we saw the approval of two additional first-in-class switches in categories that would have been thought of as challenging five years ago. One is the first incontinence medication available for sale without a prescription, Merck’s Oxytrol for Women, and the other is the first nasal allergy steroid, Sanofi’s Nasacort Allergy 24HR.Continue reading
